Unknown OBSERVATIONAL NCT03595956

Transgender Cohort Study of Gender Affirmation and HIV-related Health

Sponsor: Callen-Lorde Community Health Center

Conditions Depression, Anxiety Gender Dysphoria Gender Identity HIV/AIDS STI Transsexualism

Interventions Medical gender affirmation

Updated 10 times since 2018 Last updated: Nov 16, 2020 Started: Feb 11, 2019 Primary completion: Dec 31, 2020 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Depression, Anxiety and Gender Dysphoria and is currently ongoing. Callen-Lorde Community Health Center leads this study, which shows 10 recorded versions since 2019 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2022 — Jul 2024 [monthly]

Unknown Status

Status: Enrolling By Invitation → Unknown Status
Jan 2021 — Dec 2022 [monthly]

Enrolling By Invitation
Dec 2020 — Jan 2021 [monthly]

Enrolling By Invitation

▶ Show 5 earlier versions

Jun 2020 — Dec 2020 [monthly]

Enrolling By Invitation
May 2019 — Jun 2020 [monthly]

Enrolling By Invitation

Status: Not Yet Recruiting → Enrolling By Invitation
Jan 2019 — May 2019 [monthly]

Not Yet Recruiting
Sep 2018 — Jan 2019 [monthly]

Not Yet Recruiting
Aug 2018 — Sep 2018 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Callen-Lorde Community Health Center
Fenway Community Health
Patient-Centered Outcomes Research Institute

Data source: Fenway Community Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States